October 17, 2023 | Vensana Capital® Portfolio News

Evident Vascular Exits Stealth with $35 Million Series A Funding to Develop Vascular Imaging Platform

20

Novel FDA PMA & de novo 510k approvals

55

U.S. Commercial Product Launches

39

Level I Clinical Trials

29

Strategic Financings

30

Exits by IPO or M&A